Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL
Clinical trial NCT07012980 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07012980
- Sponsor
- Shanghai Zhongshan Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-01
- Primary completion
- 2026-07-31
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.